|
|
|
Volumn 78, Issue 2, 1996, Pages 92-96
|
|
Xenotransplantation: Benefits, risks and regulation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANIMAL TISSUE;
HEALTH CARE COST;
HEALTH CARE POLICY;
HUMAN;
IMMUNOBIOLOGY;
INFECTION;
INFORMED CONSENT;
MEDICAL ETHICS;
NONHUMAN;
ORGAN DONOR;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
XENOTRANSPLANTATION;
ANIMAL EXPERIMENTATION;
ANIMAL ORGANS;
BODY PARTS AND FLUIDS;
CLINICAL APPROACH/SOURCE;
DIABETES;
GOVERNMENT REGULATION;
HEALTH CARE AND PUBLIC HEALTH;
HEALTH HAZARDS;
INSTITUTE OF MEDICINE;
ORGAN DONATION;
REGULATION;
RESOURCE ALLOCATION;
RISKS AND BENEFITS;
SCARCITY;
SPECIESISM;
TECHNICAL EXPERTISE;
THERAPEUTIC RESEARCH;
TISSUE DONATION;
UNITED STATES;
ADVISORY COMMITTEES;
ANIMAL EXPERIMENTATION;
ANIMALS;
CELL TRANSPLANTATION;
ETHICS COMMITTEES, RESEARCH;
ETHICS, MEDICAL;
GOVERNMENT REGULATION;
HUMAN BODY;
HUMANS;
ORGAN TRANSPLANTATION;
PROFESSIONAL REVIEW ORGANIZATIONS;
RESOURCE ALLOCATION;
RISK ASSESSMENT;
SOCIAL CONTROL, FORMAL;
THERAPEUTIC HUMAN EXPERIMENTATION;
TISSUE AND ORGAN PROCUREMENT;
TISSUE DONORS;
TRANSPLANTATION, HETEROLOGOUS;
VIRUS DISEASES;
|
|
EID: 0029880395
PISSN: 00358843
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|
